Bio Techne (TECH) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Bio techne Corp  (NASDAQ: TECH)

Select the Financial Report: Select the Period:


Description of Bio Techne's Business Segments


Bio-Techne Corporation is a prominent global life sciences company, recognized for its extensive array of innovative solutions tailored to meet the needs of customers across various sectors, including academic research, clinical laboratories, and pharmaceutical companies. Below is a comprehensive overview of the key segments, products, and services offered by Bio-Techne:

1. Diagnostics and Genomics Segment:

This segment is pivotal in providing tools that facilitate the detection and analysis of genetic and molecular data, crucial for diagnostic purposes.

- Assays and Kits: Bio-Techne offers a wide range of assays and kits designed to analyze gene expression, RNA splicing, and more. These products leverage advanced methodologies to yield reliable data for both clinical and research settings.

- Reagents: The company supplies high-quality reagents that are essential in conducting molecular biology experiments. These reagents ensure accuracy and reproducibility in various applications.

- Real-Time PCR Solutions: Bio-Techne provides reagents and kits specific for quantitative PCR (qPCR), which is fundamental in gene expression analysis and other genomic applications.

- Nucleic Acid Purification: Products designed for the extraction and purification of DNA and RNA, critical for downstream applications such as sequencing and cloning.

- Bioinformatics Tools: The segment also includes software and analytical tools that aid in interpreting genomic data, helping researchers to make informed decisions based on complex data sets.

Protein Sciences Segment:

Bio-Technes Protein Sciences segment is well-established, providing essential products for protein research and validation.

- Antibodies: The company boasts an extensive portfolio of antibodies validated for a myriad of applications, including Western blotting, immunohistochemistry, and ELISA. These antibodies facilitate research into protein function and expression, paving the way for advancements in diagnostics and therapies.

- Immunoassays: Bio-Techne develops robust immunoassays that are utilized for the quantitative measurement of proteins, offering essential tools in both clinical diagnostics and research.

- Proteins: The company provides recombinant proteins that serve as important standards and reagents in various experimental settings. These proteins cover a diverse range of biological functions.

- RNA Interference (RNAi): The segment includes RNAi products designed for gene silencing, enabling researchers to study gene function and regulation.

Cell and Gene Therapy Segment:

Bio-Techne is at the forefront of supporting new therapeutics through its offerings in this rapidly evolving field.

- Bioactive Molecules: The segment offers an array of bioactive molecules such as cytokines and growth factors, which are critical in the development of cell-based therapies.

- Cell Culture Media: Customized media formulations are available to support the proliferation and maintenance of various cell types used in therapeutic contexts.

- Gene Editing Tools: Bio-Techne provides innovative tools and technologies that assist in precise genome editing, facilitating research and development initiatives aimed at curing genetic disorders.

Clinical Controls Segment:

This segment plays a crucial role in ensuring the reliability and accuracy of diagnostic tests.

- Quality Control Materials: Bio-Techne supplies controls that are essential for validating the performance of in vitro diagnostic devices. This ensures that diagnostic results are trustworthy and pivotal for patient management.

- Proficiency Testing: The segment may also encompass services related to proficiency testing, helping laboratories maintain compliance with regulatory standards.

Custom Services Segment:

Bio-Techne recognizes the unique needs of its customers and offers bespoke solutions through this segment.

- Custom Assay Development: Expertise in developing tailor-made assays that fit specific research needs, providing researchers with tools that are uniquely suited to their experiments.

- Protein Expression and Purification: The company offers services for optimized protein expression and purification, catering to the diverse requirements of their clientele.

- Oligonucleotide Synthesis: Custom oligonucleotide synthesis services allow researchers to acquire tailored DNA or RNA sequences for their specific applications.

Conclusion:

Bio-Techne Corporation embodies a dedication to advancing scientific research and breakthroughs in human health through its vast array of innovative solutions. By focusing on diagnostic capabilities, protein and genomic sciences, therapeutic development, quality control measures, and custom services, the company plays a significant role in empowering researchers and clinicians alike. This commitment to innovation and customer satisfaction positions Bio-Techne as a leader in the life sciences industry, making a meaningful impact on research and patient care worldwide.


Composition of Bio techne Corp Revenues by Segments

 
Consumables    306.71 % of total Revenue
Instruments    34.44 % of total Revenue
Service    29.36 % of total Revenue
Product and Services    370.51 % of total Revenue
Royalty    7.78 % of total Revenue
US    197.82 % of total Revenue
EMEA Excluding UK    91.6 % of total Revenue
GB    17.52 % of total Revenue
Diagnostics and Spatial Biology    94.73 % of total Revenue
CN    32.4 % of total Revenue
Rest of World    12.23 % of total Revenue
Protein Sciences    211.98 % of total Revenue
Member    377.03 % of total Revenue
Intersegment Elimination    -0.43 % of total Revenue

Q4 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Consumables 985.12 306.71 %
Instruments 110.63 34.44 %
Service 94.30 29.36 %
Product and Services 1,190.05 370.51 %
Royalty 24.99 7.78 %
US 635.37 197.82 %
EMEA Excluding UK 294.22 91.6 %
GB 56.28 17.52 %
Diagnostics and Spatial Biology 304.27 94.73 %
CN 104.06 32.4 %
Rest of World 39.29 12.23 %
Protein Sciences 680.85 211.98 %
Member 1,210.99 377.03 %
Intersegment Elimination -1.39 -0.43 %
Total 321.19 100 %




Q4 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Consumables - 282.81 %
Instruments - 299.91 %
Service - -
Product and Services - 288.34 %
Royalty - -
US - -
EMEA Excluding UK - -
GB - -
Diagnostics and Spatial Biology - 255.51 %
CN - -
Rest of World - 405.79 %
Protein Sciences - 201.06 %
Member - -
Intersegment Elimination - -
Total -73.66 % 3.18 %




Q4 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Diagnostics and Spatial Biology 37.70 12.39 %
Protein Sciences 359.40 52.79 %
Member 397.10 32.79 %
Total 54.62 17.01 %




Q4 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Diagnostics and Spatial Biology - 265.33 %
Protein Sciences - 259.4 %
Member - -
Total -25.58 % 7 %




Annual Report on Bio techne Corp Divisions, Sales by Country

 
Consumables   Consumables Segment contribution to total sales 79.74 % of total Revenue
Instruments   Instruments Segment contribution to total sales 9.19 % of total Revenue
Product and Services   Product and Services Segment contribution to total sales 98.09 % of total Revenue
Diagnostics and Spatial Biology   Diagnostics and Spatial Biology Segment contribution to total sales 28.4 % of total Revenue
Rest of World   Rest of World Segment contribution to total sales 3.08 % of total Revenue
Protein Sciences   Protein Sciences Segment contribution to total sales 71.37 % of total Revenue
United States   United States Segment contribution to total sales 56.04 % of total Revenue
EMEA excluding United Kingdom   EMEA excluding United Kingdom Segment contribution to total sales 21.84 % of total Revenue
United Kingdom   United Kingdom Segment contribution to total sales 4.5 % of total Revenue
APAC excluding Greater China   APAC excluding Greater China Segment contribution to total sales 6.34 % of total Revenue
Greater China   Greater China Segment contribution to total sales 8.24 % of total Revenue
Services   Services Segment contribution to total sales 9.15 % of total Revenue
Royalty revenues   Royalty revenues Segment contribution to total sales 1.94 % of total Revenue
InterEliminations   InterEliminations Segment contribution to total sales -0.08 % of total Revenue
Revenues from External Customers and Long-Lived Assets FromExternalCustomersAndLongLivedAssetsLineItems   Revenues from External Customers and Long-Lived Assets FromExternalCustomersAndLongLivedAssetsLineItems Segment contribution to total sales 99.77 % of total Revenue
Protein Sciences Consumables   Protein Sciences Consumables Segment contribution to total sales 56.11 % of total Revenue
Diagnostics and Spatial Biology Consumables   Diagnostics and Spatial Biology Consumables Segment contribution to total sales 23.29 % of total Revenue
Other revenue   Other revenue Segment contribution to total sales 0.34 % of total Revenue
Other revenue Consumables   Other revenue Consumables Segment contribution to total sales 0.34 % of total Revenue


Twelve months ended 2025
TECH s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Consumables 972.29 79.74 %
Instruments 112.09 9.19 %
Product and Services 1,195.94 98.09 %
Diagnostics and Spatial Biology 346.26 28.4 %
Rest of World 37.55 3.08 %
Protein Sciences 870.25 71.37 %
Total 1,219.27 100 %
United States 683.23 56.04 %
EMEA excluding United Kingdom 266.31 21.84 %
United Kingdom 54.83 4.5 %
APAC excluding Greater China 77.26 6.34 %
Greater China 100.46 8.24 %
Services 111.57 9.15 %
Royalty revenues 23.69 1.94 %
InterEliminations -1.03 -0.08 %
Revenues from External Customers and Long-Lived Assets FromExternalCustomersAndLongLivedAssetsLineItems 1,216.51 99.77 %
Protein Sciences Consumables 684.17 56.11 %
Diagnostics and Spatial Biology Consumables 283.97 23.29 %
Other revenue 4.15 0.34 %
Other revenue Consumables 4.15 0.34 %


Twelve months ended 2025
TECH s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Diagnostics and Spatial Biology 21.32 6.16 %
Protein Sciences 370.35 42.56 %
Total 73.40 6.02 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Consumables 4.75 % -
Instruments 3.52 % -
Product and Services 5.3 % -
Diagnostics and Spatial Biology 6.09 % -13.13 %
Rest of World 2.87 % -
Protein Sciences 4.73 % 4.39 %
United States 3.87 % -
EMEA excluding United Kingdom 10.3 % -
United Kingdom 9.63 % -
APAC excluding Greater China 4.55 % -
Greater China 1 % -
Services 12.4 % -
Royalty revenues 1.49 % -
InterEliminations - -
Revenues from External Customers and Long-Lived Assets FromExternalCustomersAndLongLivedAssetsLineItems 5.12 % -
Protein Sciences Consumables 4.03 % -
Diagnostics and Spatial Biology Consumables 6.62 % -
Other revenue Consumables -0.02 % -
EMEA, excluding United Kingdom - -
APAC, excluding Greater China - -
InterEliminations Other revenue - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.